Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nurix Therapeutics (NRIX) Tax Provisions (2019 - 2025)

Nurix Therapeutics (NRIX) has disclosed Tax Provisions for 5 consecutive years, with $760000.0 as the latest value for Q2 2025.

  • Quarterly Tax Provisions rose 744.44% to $760000.0 in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $760000.0 through Nov 2025, up 181.48% year-over-year, with the annual reading at $760000.0 for FY2025, 181.48% up from the prior year.
  • Tax Provisions for Q2 2025 was $760000.0 at Nurix Therapeutics, up from $8000.0 in the prior quarter.
  • The five-year high for Tax Provisions was $760000.0 in Q2 2025, with the low at -$100000.0 in Q3 2021.
  • Average Tax Provisions over 3 years is $125777.8, with a median of $82000.0 recorded in 2024.
  • The sharpest move saw Tax Provisions crashed 99.85% in 2021, then soared 744.44% in 2025.
  • Over 3 years, Tax Provisions stood at $31000.0 in 2021, then plummeted by 74.19% to $8000.0 in 2024, then soared by 9400.0% to $760000.0 in 2025.
  • According to Business Quant data, Tax Provisions over the past three periods came in at $760000.0, $8000.0, and $82000.0 for Q2 2025, Q4 2024, and Q3 2024 respectively.